Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings results on February 10, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $2.42, beating the consensus estimate of $2.39 by $0.03 per share. Revenue came in at $2.2B, beating the estimate of $2.2B.
Zimmer Biomet Holdings's stock moved following the earnings release. The stock currently trades at $92.00 with a market capitalization of $18.3B.


